Holen Sie sich die Stockscreener-App
1.39
2.80%
-0.04
Handel nachbörslich:
1.37
-0.02
-1.44%
Schlusskurs vom Vortag:
$1.43
Offen:
$1.43
24-Stunden-Volumen:
138.85K
Relative Volume:
0.24
Marktkapitalisierung:
$1.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1628
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
+2.96%
1M Leistung:
-59.83%
6M Leistung:
-84.91%
1J Leistung:
-95.41%
1-Tages-Spanne:
$1.3526
$1.4595
1-Wochen-Bereich:
$1.31
$1.4934
52-Wochen-Spanne:
$1.30
$75.60
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Vergleichen Sie OGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.39 | 1.18M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
What drives Oragenics Inc. stock priceMarket-crushing profits - PrintWeekIndia
When is the best time to buy Oragenics Inc. stockExplosive market performance - jammulinksnews.com
Why Oragenics Inc. stock attracts strong analyst attentionShort Term High Return Strategy - Newser
Oragenics Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - PrintWeekIndia
What analysts say about Oragenics Inc. stockFree AI-Backed Trading Signals - PrintWeekIndia
Oragenics Announces Approval of Common Stock Listing on NYSE MKT - AOL.com
Is Oragenics Inc. a good long term investmentPhenomenal returns - jammulinksnews.com
Oragenics Partners With Sterling For U.S.-Based Manufacturing Of Concussion Drug ONP-002 - Nasdaq
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials - citybuzz -
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development - The Manila Times
Oragenics partners with Sterling for concussion drug production By Investing.com - Investing.com South Africa
Oragenics partners with Sterling for concussion drug production - Investing.com
What makes Oragenics Inc. stock price move sharplyHigh Probability Setups - Newser
How Oragenics Inc. stock performs during market volatilityFree Real-Time Market Predictions - Newser
Best Momentum Stock to Buy for July 7th - The Globe and Mail
Silicon Valley - FinancialContent
Oragenics Closes $16.5 Million Offering of Preferred Stock, Warrants - MarketScreener
Oragenics Raises $16.5M Through Public Offering - TipRanks
Oragenics, Inc. Successfully Closes $16.5 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq
Oragenics' Stock Takes A Hit With New Offering Announcement - Finimize
Form 424B5 ORAGENICS INC - StreetInsider
Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN
Oragenics Inc. Announces $20 Million Preferred Stock and Warrant Offering to Fund Concussion Trials and R&D - citybuzz -
Oragenics stock tumbles after announcing $20 million preferred stock offering - Investing.com
Why Is Oragenics Stock (OGEN) Down 55% Today? - TipRanks
Oragenics announces $20 million preferred stock offering - Investing.com Australia
Oragenics, Inc. Announces $20 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq
Oragenics announces $20 million preferred stock offering By Investing.com - Investing.com UK
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants - TradingView
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):